\-\ Texto\\:\\ \ \(0\)\
\-\ due\\ to\\ the\\ size\\ of\\ the\\ mass\\ and\\ the\\ presentation\\ with\\ acute\\ hemorrhage\\,\\ treatment\\ was\\ indicated\\.\\ \\ the\\ patient\\ underwent\\ selective\\ catheter\\ based\\ embolization\\ of\\ the\\ lesion\\.\ \(0\)\
\-\ \\â\\€\\¢\\ contrast\\ enhanced\\ ct\\ of\\ the\\ abdomen\\ and\\ pelvis\\ demonstrates\\ a\\ large\\ enhancing\\ mass\\ in\\ the\\ left\\ kidney\\.\\ \\ the\\ mass\\ has\\ multiple\\ foci\\ of\\ fat\\ density\\.\\ \\ area\\ of\\ increased\\ density\\ within\\ the\\ mass\\ is\\ consistent\\ with\\ hemorrhage\\.\ \(0\)\
\-\ \\â\\€\\¢\\ catheter\\ angiogram\\ shows\\ large\\ mass\\ feed\\ by\\ interlobar\\ artery\\ with\\ prominent\\ neovascularity\\ and\\ delayed\\ washout\\.\ \(0\)\
\-\ \\â\\€\\¢\\ post\\-embolization\\ images\\ show\\ absent\\ flow\\ to\\ the\\ mass\\.\ \(0\)\
\-\ angiomyolipoma\ \(35\)\
\-\ \\â\\€\\¢\\ angiomyolipoma\ \(2\)\
\-\ \\â\\€\\¢\\ renal\\ cell\\ carcinoma\\ surrounding\\ renal\\ sinus\\ fat\ \(0\)\
\-\ 22\\ y\\/o\\ woman\\ presents\\ with\\ acute\\ left\\ sided\\ abdominal\\ pain\\.\ \(1\)\
\-\ this\\ woman\\ was\\ known\\ to\\ have\\ tuberous\\ sclerosis\\ \\(ts\\)\\.\\ \\ aml\\ occurs\\ in\\ a\\ majority\\ of\\ ts\\ patients\\,\\ though\\ often\\ small\\ and\\ uncomplicated\\.\\ \\ \ \(0\)\
\-\ symptoms\\ rarely\\ occur\\ in\\ patients\\ with\\ amls\\ less\\ than\\ 4cm\\ in\\ size\\.\\ \\ tumors\\ greater\\ than\\ 4cm\\ are\\ symptomatic\\ 80\\-90\\%\\ of\\ the\\ time\\ and\\ 50\\-60\\%\\ bleed\\ spontaneously\\.\ \(0\)\
\-\ embolization\\ of\\ angiomyolipomas\\ is\\ an\\ effective\\,\\ minimally\\ invasive\\ treatment\\.\\ \\ the\\ technical\\ success\\ rate\\ is\\ near\\ 100\\%\\.\\ \\ recurrence\\ \\(increase\\ in\\ size\\ \\>2cm\\ on\\ follow\\-up\\ imaging\\ and\\/or\\ recurrent\\ symptoms\\ requiring\\ repeat\\ embolization\\)\\ is\\ rare\\ in\\ sporadic\\ amls\\.\\ the\\ recurrence\\ rate\\ is\\ higher\\ in\\ patients\\ with\\ ts\\ and\\ lifelong\\ imaging\\ is\\ recommended\\.\\ \ \(0\)\
\-\ kothary\\ n\\,\\ soulen\\ mc\\,\\ clark\\ tw\\,\\ et\\ al\\.\\ renal\\ angiomyolipoma\\:\\ long\\-term\\ results\\ after\\ arterial\\ embolization\\.\\ \\ j\\ vasc\\ interv\\ radiol\\.\\ 2005\\;\\ 16\\:45\\-50\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ts\\:\\ 0\\.07429201518219528\ \(0\)\
\-\ embolization\\:\\ 0\\.06052070748311818\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.05876756780802493\ \(0\)\
\-\ amls\\:\\ 0\\.05479909134245169\ \(0\)\
\-\ 4cm\\:\\ 0\\.04197476469933208\ \(0\)\
\-\ neovascularity\\:\\ 0\\.03351908145994866\ \(0\)\
\-\ 16\\:45\\-50\\:\\ 0\\.03351908145994866\ \(0\)\
\-\ size\\:\\ 0\\.03267919244918751\ \(0\)\
\-\ catheter\\:\\ 0\\.031224245039195166\ \(0\)\
\-\ kothary\\:\\ 0\\.030883540849454574\ \(0\)\
\-\ soulen\\:\\ 0\\.030883540849454574\ \(0\)\
\-\ clark\\:\\ 0\\.030883540849454574\ \(0\)\
\-\ interv\\:\\ 0\\.030883540849454574\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.029791147368743113\ \(0\)\
\-\ vasc\\:\\ 0\\.029341848423187787\ \(0\)\
\-\ renal\\:\\ 0\\.029286793339825885\ \(0\)\
\-\ recurrence\\:\\ 0\\.02834921740482216\ \(0\)\
\-\ interlobar\\:\\ 0\\.028248000238960486\ \(0\)\
\-\ tw\\:\\ 0\\.028248000238960486\ \(0\)\
\-\ mass\\:\\ 0\\.027113178865723907\ \(0\)\
\-\ post\\-embolization\\:\\ 0\\.0267063078126937\ \(0\)\
\-\ 50\\-60\\:\\ 0\\.0267063078126937\ \(0\)\
\-\ lifelong\\:\\ 0\\.025612459628466394\ \(0\)\
\-\ rate\\:\\ 0\\.02532868053593797\ \(0\)\
\-\ patients\\:\\ 0\\.025227086684783566\ \(0\)\
\-\ 80\\-90\\:\\ 0\\.02476400506073176\ \(0\)\
\-\ feed\\:\\ 0\\.023766422306102514\ \(0\)\
\-\ technical\\:\\ 0\\.023766422306102514\ \(0\)\
\-\ angiomyolipomas\\:\\ 0\\.023222312634464972\ \(0\)\
\-\ radiol\\:\\ 0\\.022976919017972306\ \(0\)\
\-\ \\%\\:\\ 0\\.022737502281513396\ \(0\)\
\-\ washout\\:\\ 0\\.022529074775932828\ \(0\)\
\-\ aml\\:\\ 0\\.022529074775932828\ \(0\)\
\-\ selective\\:\\ 0\\.022323495987832922\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.021629327636319664\ \(0\)\
\-\ density\\:\\ 0\\.021381227048364707\ \(0\)\
\-\ 2cm\\:\\ 0\\.02098738234966604\ \(0\)\
\-\ sporadic\\:\\ 0\\.02098738234966604\ \(0\)\
\-\ success\\:\\ 0\\.019789355556358454\ \(0\)\
\-\ fat\\:\\ 0\\.019763591808985806\ \(0\)\
\-\ mc\\:\\ 0\\.0190450795977041\ \(0\)\
\-\ n\\:\\ 0\\.018879736966754525\ \(0\)\
\-\ bleed\\:\\ 0\\.018569174111186967\ \(0\)\
\-\ effective\\:\\ 0\\.018495341085114334\ \(0\)\
\-\ spontaneously\\:\\ 0\\.018351841739171953\ \(0\)\
\-\ uncomplicated\\:\\ 0\\.01828207315107995\ \(0\)\
\-\ requiring\\:\\ 0\\.0179512314134768\ \(0\)\
\-\ long\\-term\\:\\ 0\\.0179512314134768\ \(0\)\
\-\ tuberous\\:\\ 0\\.017888382356628086\ \(0\)\
\-\ 2005\\:\\ 0\\.017531657051617994\ \(0\)\
\-\ than\\:\\ 0\\.017026987489872806\ \(0\)\
\-\ minimally\\:\\ 0\\.016905211298477097\ \(0\)\
\-\ 100\\:\\ 0\\.016409538987210013\ \(0\)\
\-\ invasive\\:\\ 0\\.016325968999686153\ \(0\)\
\-\ symptoms\\:\\ 0\\.016195113892761515\ \(0\)\
\-\ acute\\:\\ 0\\.01604470972704559\ \(0\)\
\-\ majority\\:\\ 0\\.015971094703898247\ \(0\)\
\-\ higher\\:\\ 0\\.01593363350069288\ \(0\)\
\-\ angiogram\\:\\ 0\\.015716301128677865\ \(0\)\
\-\ rarely\\:\\ 0\\.015578021112819024\ \(0\)\
\-\ repeat\\:\\ 0\\.01528413641965687\ \(0\)\
\-\ imaging\\:\\ 0\\.015224896003464659\ \(0\)\
\-\ though\\:\\ 0\\.015070297186490042\ \(0\)\
\-\ woman\\:\\ 0\\.015010668802197006\ \(0\)\
\-\ j\\:\\ 0\\.014675632571730941\ \(0\)\
\-\ 22\\:\\ 0\\.01449266965027011\ \(0\)\
\-\ arterial\\:\\ 0\\.014221842618755405\ \(0\)\
\-\ large\\:\\ 0\\.01420944815080669\ \(0\)\
\-\ absent\\:\\ 0\\.014081865534638612\ \(0\)\
\-\ indicated\\:\\ 0\\.014059028941253778\ \(0\)\
\-\ near\\:\\ 0\\.014059028941253778\ \(0\)\
\-\ foci\\:\\ 0\\.013946859114650361\ \(0\)\
\-\ enhanced\\:\\ 0\\.013902901615026499\ \(0\)\
\-\ al\\:\\ 0\\.013773998376715923\ \(0\)\
\-\ and\\/or\\:\\ 0\\.013731983790455144\ \(0\)\
\-\ recurrent\\:\\ 0\\.013711149319867215\ \(0\)\
\-\ increase\\:\\ 0\\.013628934627801945\ \(0\)\
\-\ recommended\\:\\ 0\\.013469653480618828\ \(0\)\
\-\ prominent\\:\\ 0\\.013335554093404157\ \(0\)\
\-\ occurs\\:\\ 0\\.013335554093404157\ \(0\)\
\-\ et\\:\\ 0\\.01329809289019879\ \(0\)\
\-\ delayed\\:\\ 0\\.01322425986412616\ \(0\)\
\-\ treatment\\:\\ 0\\.013152980681375567\ \(0\)\
\-\ results\\:\\ 0\\.01311613083248915\ \(0\)\
\-\ symptomatic\\:\\ 0\\.01290868222317191\ \(0\)\
\-\ is\\:\\ 0\\.01282792650307359\ \(0\)\
\-\ rare\\:\\ 0\\.01261730113563991\ \(0\)\
\-\ based\\:\\ 0\\.012390457651205174\ \(0\)\
\-\ tumors\\:\\ 0\\.012204244705971487\ \(0\)\
\-\ greater\\:\\ 0\\.012204244705971487\ \(0\)\
\-\ occur\\:\\ 0\\.012190291364188359\ \(0\)\
\-\ sided\\:\\ 0\\.01201340917546253\ \(0\)\
\-\ sinus\\:\\ 0\\.01188273372487619\ \(0\)\
\-\ pelvis\\:\\ 0\\.011806431203770451\ \(0\)\
\-\ sclerosis\\:\\ 0\\.011670400127096369\ \(0\)\
\-\ kidney\\:\\ 0\\.011446324924144524\ \(0\)\
\-\ in\\:\\ 0\\.011215895859246329\ \(0\)\
\-\ presentation\\:\\ 0\\.011191637393502214\ \(0\)\
\-\ underwent\\:\\ 0\\.011149034355430491\ \(0\)\
\-\ less\\:\\ 0\\.011003574160922746\ \(0\)\
\-\ \\>\\:\\ 0\\.010795313743986937\ \(0\)\
\-\ flow\\:\\ 0\\.010737847440526678\ \(0\)\
\-\ surrounding\\:\\ 0\\.010681236746634088\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.010570482857192936\ \(0\)\
\-\ often\\:\\ 0\\.01036681957612035\ \(0\)\
\-\ known\\:\\ 0\\.010281563058797794\ \(0\)\
\-\ area\\:\\ 0\\.010273141612677821\ \(0\)\
\-\ enhancing\\:\\ 0\\.010189937387394522\ \(0\)\
\-\ show\\:\\ 0\\.009973976937230516\ \(0\)\
\-\ artery\\:\\ 0\\.009675018981399996\ \(0\)\
\-\ abdomen\\:\\ 0\\.009625035220135728\ \(0\)\
\-\ carcinoma\\:\\ 0\\.009208850456334093\ \(0\)\
\-\ time\\:\\ 0\\.009177190978096246\ \(0\)\
\-\ y\\/o\\:\\ 0\\.008998589466994831\ \(0\)\
\-\ shows\\:\\ 0\\.008932979846877865\ \(0\)\
\-\ cell\\:\\ 0\\.008776580652401089\ \(0\)\
\-\ due\\:\\ 0\\.008670255334421444\ \(0\)\
\-\ abdominal\\:\\ 0\\.00812136592441869\ \(0\)\
\-\ consistent\\:\\ 0\\.007966913569700392\ \(0\)\
\-\ increased\\:\\ 0\\.007948611337641276\ \(0\)\
\-\ \\;\\:\\ 0\\.007701221248869177\ \(0\)\
\-\ was\\:\\ 0\\.007515418419875945\ \(0\)\
\-\ small\\:\\ 0\\.007485077126924406\ \(0\)\
\-\ contrast\\:\\ 0\\.00727291135668405\ \(0\)\
\-\ left\\:\\ 0\\.007270762503976538\ \(0\)\
\-\ demonstrates\\:\\ 0\\.007097419017692722\ \(0\)\
\-\ have\\:\\ 0\\.007035886229525064\ \(0\)\
\-\ multiple\\:\\ 0\\.006843368834521935\ \(0\)\
\-\ the\\:\\ 0\\.006833614833259069\ \(0\)\
\-\ after\\:\\ 0\\.00672243803273461\ \(0\)\
\-\ presents\\:\\ 0\\.006637430781398957\ \(0\)\
\-\ lesion\\:\\ 0\\.0066180807072260634\ \(0\)\
\-\ images\\:\\ 0\\.006232942554940509\ \(0\)\
\-\ within\\:\\ 0\\.006198218282836812\ \(0\)\
\-\ \\,\\:\\ 0\\.0061758950308126405\ \(0\)\
\-\ has\\:\\ 0\\.006101520800358471\ \(0\)\
\-\ \\(\\:\\ 0\\.005493245066493236\ \(0\)\
\-\ \\)\\:\\ 0\\.005426142145348327\ \(0\)\
\-\ by\\:\\ 0\\.005410155525645911\ \(0\)\
\-\ to\\:\\ 0\\.0048714993358515545\ \(0\)\
\-\ ct\\:\\ 0\\.0045448808113765895\ \(0\)\
\-\ an\\:\\ 0\\.00449302229766057\ \(0\)\
\-\ are\\:\\ 0\\.004429178222546014\ \(0\)\
\-\ \\:\\:\\ 0\\.004297622874489221\ \(0\)\
\-\ and\\:\\ 0\\.004106669332293957\ \(0\)\
\-\ pain\\:\\ 0\\.003968091891751843\ \(0\)\
\-\ this\\:\\ 0\\.0036545141190651447\ \(0\)\
\-\ of\\:\\ 0\\.0035438418493684695\ \(0\)\
\-\ patient\\:\\ 0\\.003257003539606038\ \(0\)\
\-\ a\\:\\ 0\\.0030159680746661695\ \(0\)\
\-\ on\\:\\ 0\\.0027524373093742514\ \(0\)\
\-\ \\.\\:\\ 0\\.002699584494094774\ \(0\)\
\-\ with\\:\\ 0\\.0026692967929252413\ \(0\)\
